StreetAlpha.app
Home › Stocks › NPCE

NeuroPace Inc (NPCE)

Members
LATEST PRICE

NeuroPace makes the RNS System, an implanted brain device that treats seizures in people with epilepsy. NPCE reports earnings on Thu, Nov 12, 2026.

Prices, price targets and earnings estimates for NPCE are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is NPCE in one of our four AI portfolios? Sign in free to see
See how it works→ Details ↓

Earnings

Earnings calendar →
Next report
Nov 12
2026 · Time not announced
Consensus EPS forecast
Members
EPS and revenue estimates
Year-ago EPS
Members
Same quarter last year
Options-implied move
Members
Move priced in by options
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated NPCE in the past 90 days, not enough for a consensus
Average 12-month target
Price targets for NPCEThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
KeybancInitiated
Sep 18Buy
HC Wainwright & Co.Reiterated
Jul 29Buy
MizuhoInitiated
Jul 23Buy
DateFirmActionRatingPrice target
Sep 18KeybancInitiatedBuy
Jul 29HC Wainwright & Co.ReiteratedBuy
Jul 23MizuhoInitiatedBuy
Loading…

Seasonality

How NPCE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in NPCE in the last 90 days.

Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NPCE is in one of them and how their past NPCE trades turned out.

See how it works→ View all auto pilots→
NPCE in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NPCE in an article yet. Here's the latest on the wider market.

macronewsFriday, October 30, 2026
Binance and Polymarket Hacks Test Crypto's Plumbing, Not Yet Macro
Binance paused withdrawals after a suspected theft of roughly $6 billion, while Polymarket halted trading for an hour after a vendor breach.
Jean Westart · 3 min read
macronewsMonday, October 26, 2026
S&P 500 Sits 2.5% Below Its Record Ahead of the Fed and Big Tech
The S&P 500 slipped 0.47% to 7,623.68, 2.5% below its record, as the Fed meets October 28 and Alphabet, Microsoft and Amazon report.
Marie Crown · 3 min read
macronewsMonday, October 26, 2026
Hightower's Stephanie Link Tells Investors to Add on Volatility
Hightower's Stephanie Link told CNBC's Squawk Box that investors should use market volatility to add to portfolios as earnings season unfolds.
Adam Landser · 2 min read

About NeuroPace

NeuroPace makes medical devices for people with epilepsy, focusing on those whose seizures are not controlled by medication. Its main product is the RNS System, an implant that monitors the brain's electrical activity and delivers small electrical pulses when it detects a seizure starting. The devices are sold mainly to epileptologists and neurosurgeons who treat patients at specialized epilepsy centers in the United States. The company is based in Mountain View, California.

Headquarters
Mountain View, CA
Summary based on the company’s 2026 annual report (10-K) ↗